Halia Therapeutics Expands to Abu Dhabi
October 16, 2025
Halia Therapeutics is expanding its global presence with a new office and five new hires in Masdar City, Abu Dhabi. This strategic move builds on Halia’s growing partnerships in the region and positions them to tap into world-class genomics resources to fuel its resilience-based drug discovery.
Recent News
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
- Sera Prognostics Appoints Scott Gleason CFO
- Merit Medical Announces Global Operations Leadership Transition
- Utah Life Sciences Innovation Caucus Breakfast
- Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors
